VERACYTE, INC. (VCYT) Current Ratio
- Current ratio · latest quarter: Value 9.16×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 9.16× | Current assets / current liabilities. $574.77M ÷ $62.74M ≈ 9.16× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 574.77M USD | Assets, Current |
| Current obligations | 62.74M USD | Liabilities, Current |
| Cash and equivalents | 299.52M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 54.18M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 8.02M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $574.77M | $62.74M | $299.52M | (m) | $54.18M | (m) | $8.02M | (m) | 9.16× |
| 2026-03-31 | $522.17M | $56.12M | $263.14M | (m) | $50.11M | (m) | $6.91M | (m) | 9.31× |
| 2025-12-31 | $488.38M | $59.94M | $362.58M | (m) | $44.66M | (m) | $4.59M | (m) | 8.15× |
| 2025-09-30 | $449.22M | $72.15M | $315.57M | (m) | $47.83M | $20.33M | $5.51M | (m) | 6.23× |
| 2025-06-30 | $414.68M | $76.43M | $219.50M | (m) | $50.81M | $25.02M | $11.45M | (m) | 5.43× |
| 2025-03-31 | $383.15M | $75.13M | $186.12M | (m) | $53.78M | $24.25M | $15.71M | (m) | 5.10× |
| 2024-12-31 | $372.27M | $78.63M | $239.09M | (m) | $46.52M | $21.75M | $8.63M | (m) | 4.73× |
| 2024-09-30 | $356.85M | $70.31M | $274.08M | (m) | $48.81M | $20.36M | $9.67M | (m) | 5.08× |
| 2024-06-30 | $321.11M | $72.34M | $235.91M | (m) | $50.30M | $19.26M | $12.08M | (m) | 4.44× |
| 2024-03-31 | $290.42M | $58.05M | $209.19M | (m) | $46.66M | $18.33M | $12.15M | (m) | 5.00× |
| 2023-12-31 | $285.62M | $61.24M | $216.45M | (m) | $40.38M | $16.13M | $12.94M | (m) | 4.66× |
| 2023-09-30 | $271.16M | $57.26M | $202.46M | (m) | $39.30M | $15.89M | $12.53M | (m) | 4.74× |
| 2023-06-30 | $259.48M | $58.15M | $191.14M | (m) | $42.37M | $11.57M | $12.89M | (m) | 4.46× |
| 2023-03-31 | $251.50M | $55.99M | $177.89M | (m) | $45.49M | $13.31M | $15.65M | (m) | 4.49× |
| 2022-12-31 | $248.64M | $62.61M | $154.25M | (m) | $44.02M | $14.29M | $11.91M | (m) | 3.97× |
| 2022-09-30 | $238.52M | $58.35M | $170.11M | (m) | $40.07M | $13.80M | $11.11M | $1.19M | 4.09× |
| 2022-06-30 | $235.04M | $59.34M | $153.45M | (m) | $40.45M | $14.60M | $10.33M | $1.13M | 3.96× |
| 2022-03-31 | $238.48M | $62.54M | $163.62M | (m) | $42.48M | $12.37M | $11.27M | $1.08M | 3.81× |
| 2021-12-31 | $243.10M | $64.15M | $173.20M | (m) | $41.46M | $11.22M | $12.36M | $1.13M | 3.79× |
| 2021-09-30 | $229.31M | $50.04M | $164.03M | (m) | $40.31M | $9.82M | $11.20M | (m) | 4.58× |
| 2021-06-30 | $371.35M | $36.10M | $327.55M | (m) | $31.86M | $6.67M | $8.47M | (m) | 10.29× |
| 2021-03-31 | $362.09M | $32.71M | $324.06M | (m) | $27.88M | $6.31M | $7.14M | (m) | 11.07× |
| 2020-12-31 | $375.68M | $16.78M | $349.36M | (m) | $18.46M | $4.66M | $3.12M | $0.00 | 22.39× |
| 2020-09-30 | $370.31M | $13.92M | $345.08M | (m) | $17.63M | $4.46M | $1.93M | (m) | 26.61× |
| 2020-06-30 | $172.69M | $13.11M | $147.45M | (m) | $15.31M | $7.04M | $2.22M | (m) | 13.18× |
| 2020-03-31 | $181.36M | $19.19M | $153.13M | (m) | $19.09M | $6.09M | $7.67M | (m) | 9.45× |
| 2019-12-31 | $187.69M | $17.47M | $159.32M | (m) | $19.33M | $6.81M | $2.33M | (m) | 10.74× |
| 2019-09-30 | $228.08M | $16.77M | $195.66M | (m) | $23.61M | $6.61M | $5.57M | $0.00 | 13.60× |
| 2019-06-30 | $219.95M | $15.32M | $192.65M | (m) | $19.63M | $5.10M | $4.06M | $0.00 | 14.36× |
| 2019-03-31 | $90.62M | $14.33M | $67.84M | (m) | $16.61M | $3.77M | $4.06M | $0.00 | 6.32× |
| 2018-12-31 | $96.95M | $13.06M | $78.00M | (m) | $13.17M | $3.40M | $2.52M | $1.36M | 7.42× |
| 2018-09-30 | $95.37M | $10.44M | $77.85M | (m) | $12.26M | $3.46M | $1.18M | (m) | 9.14× |
| 2018-06-30 | $41.63M | $10.39M | $23.76M | (m) | $13.01M | $3.05M | $1.96M | (m) | 4.01× |
| 2018-03-31 | $47.05M | $11.84M | $27.15M | (m) | $13.20M | $4.56M | $3.36M | (m) | 3.97× |
| 2017-12-31 | $53.93M | $12.03M | $33.89M | (m) | $12.72M | $5.32M | $3.85M | $0.00 | 4.48× |
| 2017-09-30 | $58.21M | $11.22M | $41.20M | (m) | $11.63M | $3.76M | $3.16M | (m) | 5.19× |
| 2017-06-30 | $62.86M | $10.80M | $46.46M | (m) | $11.03M | $3.32M | $2.35M | (m) | 5.82× |
| 2017-03-31 | $66.30M | $9.41M | $51.51M | (m) | $9.13M | $3.44M | $2.61M | (m) | 7.04× |
| 2016-12-31 | $73.63M | $11.53M | $59.22M | (m) | $8.76M | $3.48M | $2.42M | (m) | 6.38× |
| 2016-09-30 | $42.95M | $10.27M | $31.70M | (m) | $6.31M | $3.42M | $3.08M | (m) | 4.18× |
| 2016-06-30 | $47.40M | $11.84M | $38.99M | (m) | $3.39M | $3.50M | $2.71M | (m) | 4.00× |
| 2016-03-31 | $56.19M | $11.88M | $47.46M | (m) | $3.23M | $3.65M | $4.34M | (m) | 4.73× |
| 2015-12-31 | $47.91M | $14.72M | $39.08M | (m) | $3.50M | $3.77M | $5.08M | (m) | 3.25× |
| 2015-09-30 | $57.33M | $15.43M | $46.12M | (m) | $3.52M | $3.98M | $6.64M | (m) | 3.72× |
| 2015-06-30 | $60.71M | $11.80M | $51.05M | (m) | $3.59M | $3.98M | $2.69M | (m) | 5.14× |
| 2015-03-31 | $33.69M | $14.15M | $25.80M | (m) | $2.56M | $3.73M | $6.85M | (m) | 2.38× |
| 2014-12-31 | $43.35M | $17.14M | $35.01M | (m) | $3.05M | $3.70M | $7.40M | (m) | 2.53× |
| 2014-09-30 | $50.67M | $18.01M | $44.00M | (m) | $1.18M | $3.35M | $8.59M | $1.42M | 2.81× |
| 2014-06-30 | $64.18M | $17.11M | $58.00M | (m) | $1.43M | $3.30M | $8.54M | $940.00K | 3.75× |
| 2014-03-31 | $69.16M | $15.45M | $64.24M | (m) | $1.19M | $2.72M | $7.21M | $467.00K | 4.48× |
| 2013-12-31 | $76.41M | $15.39M | $71.22M | (m) | $1.14M | $2.57M | $5.29M | (m) | 4.97× |
| 2013-09-30 | $20.47M | $12.52M | $15.43M | (m) | $714.00K | $1.39M | $5.60M | (m) | 1.63× |
| 2012-12-31 | $16.38M | $8.99M | $14.00M | (m) | $569.00K | $1.05M | $1.89M | (m) | 1.82× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |